Biomedical studies are including more female subjects (finally)
By Bethany Brookshire,
Science News
| 06. 09. 2020
In 2019, 49 percent of biomedical research articles had both male and female subjects, almost double the percentage a decade years ago.
Biomedical science has historically been a male-dominated world — not just for the scientists, but also for their research subjects. Even most lab mice were male (SN: 6/18/19). But now, a new study shows that researchers are starting to include more females — from mice to humans — in their work.
In 2019, 49 percent of articles surveyed in biomedical science used both male and female subjects, almost twice as many as a decade before, according to findings published June 9 in eLife.
A study of articles published in 2009 across 10 biomedical disciplines showed a dismal picture. Only 28 percent of 841 research studies included both males and female subjects. The results were published in 2011 in Neuroscience and Biobehavioral Reviews.
The scientific world took note. In 2016, the U.S. National Institutes of Health instituted the Sex as a Biological Variable policy in an effort to correct the imbalance. Scientists had to use both males and females in NIH-funded research unless they could present a “strong justification” otherwise.
Annaliese Beery, a neuroscientist at Smith...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...